Xilio Therapeutics, Inc.
XLO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840233
No open-market purchases or sales by Xilio Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $32.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Xilio Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −1 vs. Q4 2021
- Shares held
- 18.8M
- −216.4K (−1.1%) vs. Q4 2021
- Total value
- $132.7M
- −$170.4M (−56.2%) vs. Q4 2021
- New holders
- 3
- 8 more added
- Sold out
- 4
- 13 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $32.6M |
| Q1 2026 | 24 | $22.0M |
| Q4 2025 | 37 | $25.4M |
| Q3 2025 | 36 | $18.6M |
| Q2 2025 | 35 | $16.2M |
| Q1 2025 | 35 | $16.3M |
| Q4 2024 | 35 | $24.7M |
| Q3 2024 | 33 | $12.6M |
| Q2 2024 | 32 | $13.7M |
| Q1 2024 | 31 | $13.5M |
| Q4 2023 | 34 | $9.03M |
| Q3 2023 | 31 | $33.5M |
| Q2 2023 | 32 | $41.9M |
| Q1 2023 | 32 | $51.0M |
| Q4 2022 | 28 | $42.8M |
| Q3 2022 | 29 | $48.3M |
| Q2 2022 | 33 | $52.2M |
| Q1 2022 | 41 | $132.7M |
| Q4 2021 | 42 | $303.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Xilio Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,805,413 | $19.8M | 1.93% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,759,344 | $19.5M | 2.47% | 00.0% | Unchanged |
| FMR LLC | 2,590,722 | $18.3M | 0.00% | +20,452+0.8% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,078,692 | $14.7M | 0.33% | −75,369−3.5% | Reduced |
| Ra Capital Management, L.P. | 2,002,217 | $14.2M | 0.31% | 00.0% | Unchanged |
| RiverVest Venture Management LLC | 1,441,444 | $10.2M | 10.46% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 1,191,094 | $8.42M | 0.21% | 00.0% | Unchanged |
| AJU IB Investment Co., Ltd. | 667,742 | $4.72M | 7.29% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 477,495 | $3.38M | 0.52% | 00.0% | Unchanged |
| Artal Group S.A. | 450,000 | $3.18M | 0.13% | 00.0% | Unchanged |
| Vanguard Group Inc | 416,393 | $2.94M | 0.00% | −7,831−1.8% | Reduced |
| Harvard Management Co Inc | 416,059 | $2.94M | 0.30% | 00.0% | Unchanged |
| Norges Bank | 400,000 | $2.83M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 299,756 | $2.12M | 0.00% | −24,338−7.5% | Reduced |
| FIL Ltd | 218,705 | $1.55M | 0.00% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 163,066 | $1.15M | 0.33% | −51,187−23.9% | Reduced |
| Geode Capital Management, LLC | 141,710 | $1.00M | 0.00% | +7,525+5.6% | Added |
| State Street Corp | 93,861 | $664.0K | 0.00% | +34,651+58.5% | Added |
| Northern Trust Corp | 63,573 | $449.0K | 0.00% | +539+0.9% | Added |
| Bank of New York Mellon Corp | 21,029 | $149.0K | 0.00% | +6,791+47.7% | Added |
| Charles Schwab Investment Management Inc | 16,100 | $114.0K | 0.00% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 11,284 | $80.0K | 0.00% | 00.0% | Unchanged |
| Granite Point Capital Management, L.P. | 10,000 | $71.0K | 0.04% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 5,632 | $40.0K | 0.00% | +64+1.1% | Added |
| JPMorgan Chase & Co | 4,844 | $34.0K | 0.00% | −6,842−58.5% | Reduced |
| Tower Research Capital LLC (TRC) | 4,294 | $30.0K | 0.00% | +3,333+346.8% | Added |
| Deutsche Bank AG | 4,026 | $28.0K | 0.00% | −482−10.7% | Reduced |
| American International Group, Inc. | 3,795 | $27.0K | 0.00% | −149−3.8% | Reduced |
| California State Teachers Retirement System | 3,208 | $23.0K | 0.00% | −870−21.3% | Reduced |
| Bank of America Corp | 2,611 | $19.0K | 0.00% | −2,163−45.3% | Reduced |
| Morgan Stanley | 2,104 | $14.0K | 0.00% | +1,066+102.7% | Added |
| Wells Fargo & Company | 1,663 | $12.0K | 0.00% | −2,799−62.7% | Reduced |
| STRS Ohio | 1,700 | $12.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1,243 | $8.00K | 0.00% | +1,243 | New |
| Amalgamated Bank | 1,078 | $8.00K | 0.00% | +1,078 | New |
| Amalgamated Financial Corp. | 1,078 | $8.00K | 0.00% | +1,078 | New |
| UBS Group AG | 964 | $7.00K | 0.00% | −3,013−75.8% | Reduced |
| Legal & General Group Plc | 698 | $5.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 573 | $4.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 470 | $3.00K | 0.00% | −1,115−70.3% | Reduced |
| Citigroup Inc | 323 | $2.00K | 0.00% | −1,871−85.3% | Reduced |
| Caas Capital Management LP | 0 | $0 | 0.00% | −37,019−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −29,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −20,189−100.0% | Sold out |